PD-1 antibody-bound progenitor-exhausted CD8&lt;sup&gt;+&lt;/sup&gt; T cells in lymph nodes boost PD-1-blockade anti-tumor immunity in gastrointestinal cancer. Here, CD8A is linked to neoplasm.